-
Jaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy
-
KIST Accelerates Global Expansion for Korean Quantum Deep-Tech Startups at Quantum World Congress 2026
-
Crypto, Sports, Esports: Bybit Gamifies Freedom of Choice Through ByPick
-
CityUHK researchers advance spatial omics to routine clinical use
-
Johnson Controls joins the Sustainable Tropical Data Centre Testbed 2.0 to advance next-generation AI infrastructure
-
Dr. Achyuta Samanta Conferred Honorary Citizenship by Romanian Town, Receives Multiple International Honours
-
111, Inc. Announces Establishment of the Special Committee
-
MIFF 2027 EVOLVES WITH NEW DESIGN-FOCUSED EXPERIENCES AND WIDER INTERNATIONAL REACH
